Brielle Benyon

The number of coronavirus (COVID-19) cases in the United States continues to grow, which could be extremely stressful for patients with cancer and their loved ones – especially as certain cancer therapies may cause a person to be immunocompromised.

The Clinical Treatment Act was created to expand clinical trial access to patients insured by Medicaid.

Disparities exist around the globe when it comes to understanding cancer risk factors and prevention measures.

One expert discusses exciting advances in using drug combinations to treat metastatic melanoma.

Here’s a look at what’s inside our 2019 Immunotherapy special issue.

Here’s a look at what’s inside our 2019 Rare Cancers special issue.

Here’s a sneak peek at what’s inside our Summer 2019 issue.

Here’s a sneak peak at what is inside Heal’s Summer 2019 issue.

Patients with breast cancer can still enroll in a clinical trial that is seeking to find the cause behind cardiac toxicity related to anthracycline-based treatment.

The Food and Drug Administration lifted a partial clinical hold on the CANOVA trial, examining Venclexta plus dexamethasone for some patients with relapsed/refractory myeloma.

The Food and Drug Administration approved Keytruda for the treatment of patients with metastatic small cell lung cancer.

We've got a sneak peek at what’s inside CURE®'s spring issue.

In an interview with PEOPLE, "Jeopardy!" Host Alex Trebek reported he is in “near remission” from his stage 4 pancreatic cancer diagnosis.

We've got a sneak peek at what’s inside Heal®'s spring issue.

We've got a sneak peek at what’s inside CURE®'s lung cancer special issue.

The Food and Drug Administration approved Cyramza for certain patients with hepatocellular carcinoma.

A recent clinical trial is examining the combination regimen of netupitant plus palonosetron (NEPA), with hopes that it can curb nausea and vomiting both before and after chemotherapy in patients with peripheral T-cell lymphoma, Hodgkin lymphoma, mantle cell lymphoma and diffuse large B-cell lymphoma.

We've got a sneak peek at what’s inside CURE®'s Women’s Cancers issue.

The FDA announced on March 27, 2019 that it is working to update mammography regulations, expanding the amount of information that mammography facilities must give patients and healthcare professionals.

There is still work to do in the field of molecular diagnosis for renal cell carcinoma, according to David I. Quinn, MBBS, Ph.D., FRACP, FACP.

Debu Tripathy, M.D., the editor in chief of CURE®, recently sat down at the Miami Breast Cancer Conference to discuss the importance of oncology nurses in breast cancer care and offered insight as to how they can keep up-to-date with the constant advancements in the field.

Adam Brufsky, M.D., Ph.D. discussed treatments for BRCA-positive breast cancer at the 2019 Miami Breast Cancer Conference.

During the 2019 Miami Breast Cancer Conference, an expert discussed financial toxicity and the role of healthcare providers in addressing the cost of care with their patients.

Rose Gerber, of the Community Oncology Alliance, shared her story of participating in a clinical trial and hopes for others to help educate patients with breast cancer to increase participation moving forward.

Many people believe that genetic testing for cancer can only be beneficial for individuals with a strong family history of the disease, but that is not necessarily the case.

Deborah A. Boyle, MSN, RN, AOCNS, FAAN, describes two types of cancer survivorship care plans that are increasing in popularity across the US.

We've got a sneak peek at what’s inside our Winter 2019 issue.

Alex Trebek, the long-time host of the popular game show "Jeopardy!", announced that he received a diagnosis of stage 4 pancreatic cancer.

The Food and Drug Administration (FDA) approved Keytruda (pembrolizumab) – an immunotherapy agent – for the treatment of patients with resected, high-risk, stage 3 melanoma.

The Food and Drug Administration (FDA) approved a split-dosing regimen for Darzalex (daratumumab) for the treatment of patients with multiple myeloma.